About Carelane

Carelane is a health tech startup focused on addressing the inefficiencies in clinical trials by integrating multiple essential functions into a single, streamlined system, thereby digitizing study protocols and processes. After launching in 2023, it quickly gained traction and closed its first funding round successfully in the beginning of 2024. Both founders have extensive experience working in health tech, having worked with the German government, private enterprises, and renowned research hospitals. They are driven by the vision to empower researchers and healthcare professionals, ultimately saving time that can be redirected towards groundbreaking research and innovations. Carelane stands at the forefront of transforming the clinical trial process, making it intuitive, efficient, and seamlessly integrated.

Press releases

Press
20. June 2024

Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software

Carelane founders Gustav Vella and Yannick Boerner (Photo: Carelane) Carelane Secures €800,000: Carelane has successfully closed its pre-seed funding round, gathering €800,000, led by High-Tech Gründerfonds to expand its novel clinical trial software across Europe and the US. Innovative Unified Platform: Addressing the inefficiencies in clinical trials, Carelane’s platform integrates multiple necessary functions into one system, digitizing study protocols and processes to r
 

Info & Contact

Address

Carelane GmbH
Schwachhauser Ring 54
28209 Bremen
Germany

In portfolio

20. Dec 2023

Sector

 

Dr. Natalya Baltrukovich

Investment Manager